Mouth Ulcers Treatment Market Report - Forecast (2022-2027)
Mouth Ulcers Treatment Market size is estimated to reach $2,191.3 million by 2027, growing at a CAGR of 3.7% during the forecast period 2022-2027. Ulcers in the mouth are painful sores that can form anywhere in the mouth. They can be painful, making it difficult for a person to eat, drink or brush teeth. While they are unpleasant, most mouth ulcers are usually harmless and heal on their own within a few days to a fortnight. They are normally round or oval lesions that occur on the cheeks, lips and tongue inside the mouth. Mouth ulcers can be large and white, red, yellow, or grey in color. Stress or tissue injury, excessive consumption of citrus foods like lemons, oranges, apples and others, compromised immunological issues and nutritional issues are all principal causes of mouth ulcers. Mouth ulcers can be avoided by evading tissue injury, refraining from foods that irritate the mouth, and practicing good oral hygiene. Canker sores and mouth ulcers are quite comparable and can be managed and treated in an identical way. As per an article on Aphthous Stomatitis by the National Library of Medicine, National Center for Biotechnology Information, Aphthous stomatitis affects nearly 20% of the general population. It is a little more typical in girls and women as well as amidst wealthy socioeconomic classes and nations. There are a few medicines that are utilized for mouth ulcers including antihistamines, antacids, anesthetics and corticosteroids. Different kinds of antimicrobial mouthwash help to speed up healing and avert infection of the ulcer. Oral lichen planus is an ongoing (chronic) inflammatory condition that influences mucous membranes inside the mouth. Mouth Ulcers Treatment Industry application includes treatment of conditions like Aphthous Stomatitis and Oral Lichen Planus.
The different bacterial, viral and fungal infections brought about by poor oral hygiene are set to drive the Mouth Ulcers Treatment Market. The increasing count of mouth ulcers brought about by different medical conditions or lack of nutrients like celiac or Crohn's disease, Aphthous Stomatitis and vitamin B12 or iron deficiency are set to propel the growth of the Mouth Ulcers Treatment Industry during the forecast period 2022-2027. This represents the Mouth Ulcers Treatment Industry Outlook.
Mouth Ulcers Treatment Market Report Coverage
The “Mouth Ulcers Treatment Market Report - Forecast (2022-2027)" by Industry ARC, covers an in-depth analysis of the following segments in the Mouth Ulcers Treatment Market.
Key Takeaways
- Geographically, North America (Mouth Ulcers Treatment Market share) accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the growing awareness among the population regarding the availability of effective mouth ulcer treatments for ailments like Aphthous Stomatitis in the North American region.
- Mouth Ulcers Treatment Market growth is being driven by the expanding population of the elderly who are vulnerable to mouth ulcers owing to an ensuing decrease in immunity with age and the surging application of anesthetics to induce insensitivity to pain caused by mouth ulcers. However, the greatly easy-going and laid-back attitude of people toward mouth ulcers which, if left, untreated in early phases, may result in cancer in certain cases, is one of the major factors hampering the growth of the Mouth Ulcers Treatment Market.
- Mouth Ulcers Treatment Market Detailed Analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Mouth Ulcers Treatment Market report.
Mouth Ulcers Treatment Market Segment Analysis - By Indication
The Mouth Ulcers Treatment Market based on indication can be further segmented into Aphthous Stomatitis, Oral Lichen Planus and Others. The Aphthous Stomatitis Segment held the largest Mouth Ulcers Treatment Market share in 2021. This growth is owing to the increasing predominance of Aphthous stomatitis which is a typical oral mucosal ailment that physicians and dentists observe on a regular basis. Aphthous ulcers are small, superficial sores that develop on the soft tissues of the mouth or at the bottom of the gums. Canker sores do not show up on the surface of the lips and are not contagious, contrary to cold sores. The rising pervasiveness of Aphthous Stomatitis in women in comparison with men and its typical occurrence in infants, toddlers and mature grown-ups is further propelling the growth of the Aphthous Stomatitis segment.
Furthermore, the Oral Lichen Planus segment is estimated to grow with the fastest CAGR of 4.2% during the forecast period 2022-2027 owing to the increasing cases of oral lichen planus (OLP) which is a chronic mucocutaneous ailment of the stratified squamous epithelium of uncertain etiology that influences oral and genital mucous membranes, skin, nails and scalp. Lichen planus (LP) is predicted to influence 0.5% to 2.0% of the general population. This ailment has most frequently been recorded in middle-aged patients between 30-60 years of age and is more typical in females than in males. The ailment appears to be mediated by an antigen-specific mechanism, activating cytotoxic T cells and non-specific mechanisms like mast cell degranulation and matrix metalloproteinase activation. Oral lichen planus can influence any or all areas within the mouth. It can be accelerated by psychosocial stress or by local mechanical trauma which is further fuelling the growth of this segment.
Mouth Ulcers Treatment Market Segment Analysis - By Formulation
The Mouth Ulcers Treatment Market based on formulation can be further segmented into Gels, Sprays, Mouthwashes and Lozenges. The Mouthwashes Segment held the largest Mouth Ulcers Treatment Market share in 2021. This growth is owing to the surging introduction of numerous ayurvedic herbal and flavored mouthwashes. Oral-B mouth sore mouthwash is one of the best mouthwashes for canker sores. One of the principal advantages is that it is hydrogen peroxide-based. Hydrogen peroxide has been demonstrated to be very efficient in treating canker sores. It is able to efficiently destroy the bacteria on and around the sore, which helps cure it much quicker. Lidocaine is a strong anesthetic utilized to desensitize the surfaces in the mouth. A lidocaine mouthwash is specifically efficient for treating oral mucosal lesions, also termed canker sores. Distinct medicated, as well as non-medicated mouthwashes, are used for maintaining oral hygiene and treating pain and inflammation from canker sores, which is further propelling the growth of this segment.
Furthermore, the Lozenges segment is estimated to grow with the fastest CAGR of 5.8% during the forecast period 2022-2027 owing to the low risk of adverse effects, the ease with which lozenges can be acquired and the speed with which ulcers heal. Anesthetic Sore Throat Lozenges include antibacterial, anti-inflammatory and anesthetic formulas. They assist in offering quick relief of a sore throat by desensitizing, soothing and decreasing inflammation, a cause of sore throat pain and these kinds of benefits are further fuelling the growth of this segment.
Mouth Ulcers Treatment Market Segment Analysis - By Geography
The Mouth Ulcers Treatment Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Mouth Ulcers Treatment Market) held the largest Mouth Ulcers Treatment Market share with 37% of the overall market in 2021. This growth is owing to the increasing predominance of mouth ulcer conditions like Aphthous Stomatitis and Oral Lichen Planus in the North American region. The surging utilization of technology in the area of dentistry involving intra-oral cameras, digital X-rays, optical scanners and computer-assisted designs is further propelling the growth of the Mouth Ulcers Treatment Industry in the North American region. Intra-oral cameras help in the detection of concealed and undetected defects in teeth and other portions of the cavity. MouthWatch planned to debut its novel MouthWatch Plus+ HD intraoral camera during SmileCon 2021 in Las Vegas, These kinds of innovative product launches are further fuelling the growth of the Mouth Ulcers Treatment Industry in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR over the forecast period 2022-2027. This growth is owing to factors like the surging awareness regarding mouth ulcer treatments involving anesthetics and oral hygiene and the favorable government initiatives in the Asia-Pacific region. The enormous population base and the enhanced healthcare infrastructure are further fuelling the growth of the Mouth Ulcers Treatment Market in the Asia-Pacific region.
Mouth Ulcers Treatment Market Drivers
The Rising Consumption of Tobacco among the Global Population is Propelling the Growth of the Mouth Ulcers Treatment Market
Cigarette smoking prevents aphthous ulcers by causing an increase in localized keratinization of the oral mucosa. Although quitting smoking is good for the health, it has negative side effects and causes mouth ulcers. According to the Centers for Disease Control and Prevention (CDC), in 2020, 12.5% of U.S. mature grown-ups (an estimated 30.8 million people) presently smoked cigarettes: 14.1% of men and 11% of women. Considering this percentage of smokers in the U.S., there are numerous smokers who intend to quit smoking. While quitting smoking, mouth ulcers may result. As a result, the number of cases of mouth ulcers has increased, providing an opportunity for firms to invest in the mouth ulcers treatment industry, thereby contributing to the Mouth Ulcers Treatment Industry Outlook. According to the World Health Organization (WHO), tobacco could kill more than 8 million people every year, with more than 7 million deaths resulting from direct tobacco use and 1.2 million resulting from non-smokers being exposed to second-hand smoke. Further WHO Updates indicate that low and middle-income nations account for more than 80% of the world's 1.3 billion tobacco consumers. As a result, the incidence of mouth ulcers could rise, driving the growth of the Mouth Ulcers Treatment Market. Tobacco smoke exposure harms the intrinsic immune response of the lung, resulting in a raised hazard of chronic contamination. SPLUNC1 is a secreted, multifunctional intrinsic defense protein that has antimicrobial action against Gram negative organisms. The rising consumption of tobacco among the global population is therefore propelling the growth of the Mouth Ulcers Treatment Market during the forecast period 2022-2027.
The Growing Consciousness of Dental and Oral Hygiene is Fuelling the Growth of the Mouth Ulcers Treatment Industry
Oral health is an integral part of the general health and well-being of an individual. Tooth decay and gum disease are among the most widespread conditions in the human population. Antimicrobial dental materials based on antimicrobial agent release, contact-killing and multi-functional strategies have been planned and synthesized for the avoidance of initial bacterial attachment and subsequent biofilm formation on the tooth and material surface. According to the World Health Organization (WHO), approximately 3.5 billion people are affected by oral ailments and untreated dental caries (tooth decay) in permanent teeth is the most typical health condition as per the Global Burden of Disease 2019. Greater than 530 million children lose their primary teeth owing to dental caries. This factor raises the consciousness regarding oral hygiene which in turn escalates the demand for mouth ulcer treatment market. Oral diseases are a principal public health concern owing to their higher prevalence and their effects on the quality of life of the individual. As per the World Health Organization (WHO), oral health promotion and oral disease prevention should be combined with other non-communicable disease prevention programs that share typical risk factors and social determinants and combining oral health services in primary health care is vital to offer more equitable access to comprehensive care. Innovative antimicrobial strategies for regulating oral biofilm-related infections have been reviewed. The growing consciousness of dental and oral hygiene is therefore fuelling the growth of the Mouth Ulcers Treatment Industry during the forecast period 2022-2027.
Mouth Ulcers Treatment Market Challenges
Limitations of Mouthwash with Alcohol are Hampering the Growth of the Mouth Ulcers Treatment Market
Antimicrobial mouthwash like antibacterial mouthwash normally includes alcohol. Lidocaine is a strong anesthetic applied to desensitize the surfaces in the mouth. Numerous brands of mouthwash include high levels of alcohol, with an average of 22% alcohol. For example, the recognized Listerine brand includes 26.9% alcohol. There is an ongoing debate over whether mouthwashes that include alcohol can bring about oral cancer. It is better to consult a qualified physician before using mouthwashes containing alcohol. The alcohol in the mouthwash can dissolve the mucus layer. This leaves the teeth susceptible and raises their sensitivity. If the alcohol level in the mouthwash is too high, it can irritate ulcers and canker sores in the mouth. These issues are restraining the growth of the Mouth Ulcers Treatment Market.
Mouth Ulcers Treatment Industry Outlook
Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Mouth Ulcers Treatment Market. The top 10 companies in the Mouth Ulcers Treatment Market are:
- Blistex Inc.
- Church and Dwight Co., Inc.
- Colgate Palmolive Company
- GlaxoSmithKline, plc
- Pfizer Inc.
- Patterson Dental Supply, Inc.
- Prince Care Pharma Private Limited
- Bristol-Myers Squibb Company
- 3M
- Biochemix Healthcare Private Limited
Recent Developments
- In December 2019, Forward Science received FDA clearance for OrapeuticTM, a non-opioid oral pain relief gel. Forward Science is a MedTech firm that operates R&D, it is a quality system, manufacturing, sales and support all from its Global headquarters in Houston, TX. The firm’s flagship product, OralID, accepted FDA Clearance in March of 2013 and has since transformed the way clinicians screen for early-stage oral cancer.
- In July 2019, Celgene’s plaque psoriasis medication ‘Otezla’ accepted FDA approval for the treatment of adult patients with oral ulcers.
- In April 2019, Australian-owned natural medicine firm BioRevive introduced a novel formula for its innovative MouthUlcer capsules and displayed novel look packaging for all its products. MouthUlcer capsules presently include zinc, folic acid and vitamin C to back the immune system and cure skin tissue. The capsules, which can be consumed orally, are appropriate for people of all ages who regularly experience ulcers as a result of stress or vitamin deficiency. This concludes the Mouth Ulcers Treatment Industry Outlook.
Buy Now
For more Lifesciences and Healthcare Market reports, please click here
Comments
Post a Comment